ETRA Financials

Income Statement
MetricQ3 2026
Revenue
0
Cost of Revenue
0
Gross Profit
0
Operating Expenses
25.1M
R&D
17.3M
SG&A
7.8M
Operating Income
-25061000
EBITDA
-25061000
Net Income
-23928000
EPS (Basic)
$-3.47
EPS (Diluted)
$-3.47
Shares (Diluted)
6.9M
Electra Therapeutics (ETRA) — Financials